Publications

• The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy.

  (Klintmalm GB, Saab S, Hong JC, Nashan B.) Clin Transplant. 2014 Jun;28(6):635-48 PMID: 24628264 SCOPUS ID: 2-s2.0-84901929399 03/19/2014

• Liver transplantation in highest acuity recipients: identifying factors to avoid futility.

  (Petrowsky H, Rana A, Kaldas FM, Sharma A, Hong JC, Agopian VG, Durazo F, Honda H, Gornbein J, Wu V, Farmer DG, Hiatt JR, Busuttil RW.) Ann Surg. 2014 Jun;259(6):1186-94 PMID: 24263317 SCOPUS ID: 2-s2.0-84900836924 11/23/2013

• Liver transplantation in children using organ donation after circulatory death: a case-control outcomes analysis of a 20-year experience in a single center.

  (Hong JC, Venick R, Yersiz H, Kositamongkol P, Kaldas FM, Petrowsky H, Farmer DG, Agopian V, McDiarmid SV, Hiatt JR, Busuttil RW.) JAMA Surg. 2014 Jan;149(1):77-82 PMID: 24257966 SCOPUS ID: 2-s2.0-84892734271 11/22/2013

• Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival.

  (Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC.) HPB (Oxford). 2013 Oct;15(10):794-802 PMID: 23782341 PMCID: PMC3791119 SCOPUS ID: 2-s2.0-84884292468 06/21/2013

• The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.

  (Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW.) Ann Surg. 2013 Sep;258(3):409-21 PMID: 24022434 SCOPUS ID: 2-s2.0-84884512187 09/12/2013

• Blood transfusion requirement during liver transplantation is an important risk factor for mortality.

  (Rana A, Petrowsky H, Hong JC, Agopian VG, Kaldas FM, Farmer D, Yersiz H, Hiatt JR, Busuttil RW.) J Am Coll Surg. 2013 May;216(5):902-7 PMID: 23478547 SCOPUS ID: 2-s2.0-84876677984 03/13/2013

• Liver transplantation for lethal genetic syndromes: a novel model of personalized genomic medicine.

  (Petrowsky H, Brunicardi FC, Leow VM, Venick RS, Agopian V, Kaldas FM, Zarrinpar A, Markovic D, McDiarmid SV, Hong JC, Farmer DG, Hiatt JR, Busuttil RW.) J Am Coll Surg. 2013 Apr;216(4):534-43; discussion 543-4 PMID: 23521929 03/26/2013

• Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers.

  (Yersiz H, Lee C, Kaldas FM, Hong JC, Rana A, Schnickel GT, Wertheim JA, Zarrinpar A, Agopian VG, Gornbein J, Naini BV, Lassman CR, Busuttil RW, Petrowsky H.) Liver Transpl. 2013 Apr;19(4):437-49 PMID: 23408461 SCOPUS ID: 2-s2.0-84875757880 02/15/2013

• Doppler US for suspicion of hepatic arterial ischemia in orthotopically transplanted livers: role of central versus intrahepatic waveform analysis.

  (Choi EK, Lu DS, Park SH, Hong JC, Raman SS, Ragavendra N.) Radiology. 2013 Apr;267(1):276-84 PMID: 23297323 SCOPUS ID: 2-s2.0-84875420510 01/09/2013

• Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.

  (Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM.) Liver Transpl. 2013 Mar;19(3):259-67 PMID: 23495079 PMCID: PMC3602918 SCOPUS ID: 2-s2.0-84875183700 03/16/2013

• Ischaemia-reperfusion injury in liver transplantation--from bench to bedside.

  (Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW.) Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):79-89 PMID: 23229329 PMCID: PMC3577927 SCOPUS ID: 2-s2.0-84873418617 12/12/2012

• Twenty-four years after liver transplantation, the recipient becomes a body donor.

  (Petrowsky H, Kaldas F, Peacock W, Fisher D, Hong JC, Lassman C, Busuttil RW.) Liver Transpl. 2013 Jan;19(1):110-2 PMID: 23086865 SCOPUS ID: 2-s2.0-84872000491 10/23/2012